SlideShare a Scribd company logo
MENINGITIS IN PEDIATRICS
Asmamaw A
outlines
 Introduction
 Demography and epidemology
 Predisposing factors
 Etiology and Epidemology
 Causes of meninigitis
 Bacterial meningitis
 Methods of transmission
 DX
 S&S
 Treatment
DEMOGRAPHY AND EPIDEMIOLOGY
 The highest incidence is among neonates, who
are usually infected by bacteria found in the birth
canal at the time of parturition.
◦ Group B streptococci (Streptococcus agalactiae)
account for the majority of cases; other causes include
Listeria monocytogenes, E.coli, other Gram-negative
bacilli, and enterococci.
 From age 1 to 23 months, the most common
organisms are Streptococcus pneumoniae and
Neisseria meningitidis
Predisposing factors
 Mucosal invasion of the nasopharynx
 Direct extension of bacteria across a skull
fracture in the area of the cribriform plate
 Systemic bacteremia as with endocarditis or a
urinary tract infection or pneumonia
 Asplenia, corticosteroid excess, and HIV
infection
Etiology and epidemiology of meningitis
con.
 Lack of immunity ( IgM or igG anti capsular antibody ) to
specific pathogens with young age.
 recent colonization with pathogenic bacteria .
 Close contact with invasive disease ( respiratory tract
secration)
 Crowding , poverty , black race , male .
 Defect in complement (C5- C8 ) associated with
recurrent meningococcal infection .
Etiology of meningitis con…
 Ventricular peritoneal shunts
 CSF leake due fracture,paranasal sinus
pneumococcal
 Head trauma
 Neurosurgical procedures
 Splenic dysfunction
 Immuno suppress patients with t- cell defect(
AIDS,malignancy)
Meningitis
o The brain and spinal cord are covered by
connective tissue layers collectively called the
meninges which form the blood-brain
barrier(BBB).
1-the pia mater (closest to the CNS)
2-the arachnoid mater
3-the dura mater (farthest from the CNS).
The meninges contain cerebrospinal fluid (CSF).
Meningitis is an inflammation of the meninges, which,
if severe, may become encephalitis, an
inflammation of the brain.
Central Nervous System Infections
 Meningitis is the most common causes of
fever associated with signs and symptoms
of CNS disease in children.
 Specific microbes depend on :
age, immune status, epidemiology of the
pathogen.
Causes of Meningitis
-Bacterial Infections
-Viral Infections
-Fungal Infections
(Cryptococcus neoformans
Coccidiodes immitus)
-Inflammatory diseases
(SLE)
Cancer
-Trauma to head or spine.
Viral cause of meninigitis
 Non polio enterovirus
 Mumps virus
 Measles virus
 Influenza virus
 Herpes simplex virus
Bacterial meningitis…..
Etiological Agents:
 Pneumococcal, Streptococcus
pneumoniae (38%)
 Meningococcal, Neisseria meningitidis
(14%)
 Haemophilus influenzae (4%)
 Staphylococcal, Staphylococcus aureus
(5%)
 Tuberculous, Mycobacterium
Meningococcal Meninigitis
Etiological Agent: Neisseria meningitidis
Clinical Features: sudden onset. Sudden high
fever,seisures,poor feeding,headache,nausea
and vomiting
Reservoir: Humans only. 5-15% healthy
carriers
Mode of transmission: direct contact with
patients oral or nasal secretions. Saliva.
Incubation period: 1-10 days. Usually 2-4 days
Infectious period: as long as meningococci are
present in oral secretions or until 24 hrs of
effective antibiotic therapy
Cause of Bacterial Meningitis with
age group
• Birth - 4 wks: GBS, E.coli
 4 - 12 wks: GBS, E.coli,
Pneumococcus
Salmonella, Listeria, H. Influenza
 3 mths - 3 yrs: Pneumococcus,
Meningococcus
H. Influenza
 3 yrs+ adult: Pneumococcus,
Meningococcus
Mode of transmission
 Respiratory secretion/ droplet
 Person to person contact(kissing
,saliva,contaminated food,mucus)
Bacterial Meningitis -
Pathogenesis
 Infection of upper respiratory tract
 Invasion of blood stream
(bacteraemia)
inflammation of meninges
Investigation
 LP
 Blood culture
 Latex particle agglutination
 Countercurrent immunoelectrophoresis
 DIAGNOSIS
1) Lumbar puncture
 Between L3 & L4 or L4 & L5
 Confirms DX of meningitis
 CSF
 Pressure …..usually elevated to 100-300 mmH2O ( Nl
=50-80 mmH2O )
 Gross appearance……turbid (WBC >200-400 /mm3)
 WBC count (Nl =less than 5 , lymphocyte > 75% or
monocytes )
 Usually elevated to >1000/mm3 (100 – 10,000/mm3 or
more )
 Neutrophil predominance ( 75- 95% )
 In 20 % of cases WBC < 250/mm3
 Absent pleocytosis …….sever overwhelming sepsis
with meningitis
 Pleocytosis with lymphocyte predominance…….during
early stages
 Elevated protein …usually 100-500 mg/dl (Nl = 20 - 45
mg/dl )
 Reduced glucose….usually <40 mg/dl (or <50% of serum
glucose ) ( Nl =>50mg/dl or 75 %of serum glucose )
 Gram stain : positive in 70-90 % of cases
 Culture
 Contraindications for LP
- Increased ICP
- Sever cardiopulmonary compromise
- Infection of the skin overlying the site of the LP
- Thrombocytopenia( < 20,000/mm3 ) : Relative c/I
 Traumatic LP
- Affects CSF, WBC & protein concentration
- Does not affect G/S , culture & Glucose level
- Repeat LP after sometime
2) Latex particle agglutination
- Highly sensitive but less specific
3) Blood culture : Positive in 80 -90 % of cases
4) Countercurrent immuno electrophoresis (CIE)
-Rapid & very specific
Typical Cerebrospinal Fluid Findings in
Patients with Bacterial Meningitis
Cerebrospinal Fluid Parameter Typical Finding
Opening pressure 200-500 mm H2O
White blood cell count 1000-5000/mm3
Percentage of neutrophils ≥80%
Protein 100-500 mg/dL
Glucose ≤40 mg/dL
CSF-to-serum glucose ratio ≤0.4
Gram stain Positive in 60%-90%
Culture Positive in 70%-85%
Polymerase chain reaction Promising*
CSF
 Collect 1 ml of csf in each of 3 vials
Tube 1 culture and gram stain
Tube 2 glucose,protein
Tube 3 cell count and differential
Meningitis: Clinical features
Newborn & Infants: non-specific
 Fever
 Irritability
 Lethargy
 Poor feeding
 High pitched cry, bulging AF
 Convulsions,
Kernig’s sign
Brudzinski’s sign
Meningitis: older children
 TREATMENT
A) Antibiotics
◦ Always use high dose ,parenteral (IV)
antibiotics.
◦ Initial (empirical )choice of therapy
 Vancomycin 60 mg/kg/24 hr, given every 6
hr
OR
 Ceftriaxone 100 mg /Kg /24 hr once per
day or
50 mg/Kg /dose every 12 hrs for 7 – 10
days
OR
 Patient allergic to b-lactam antibiotics
-CAF 100 mg /Kg /24hr given every 6 hr
OR
- Patient can be desensitized to the
antibiotic
◦ If patient is immuno compromised
-Ceftazidime and aminoglycoside need to be
included because of risk of gram –ve bacterial
meningitis e.g. P.aeruginosa ,E .coli
Duration of antibiotic therapy
a) Generally total of 10 days
b) Specific ( based on etiologic agent ) in
uncomplicated cases
 N .meningitidis…….5 -7 days
 H .influenzae type b……….7 10 days
 S .Pneumoniae………..10-14 days
 CSF culture –ve………7- 10 days
 Gram –ve bacilli……03 weeks or 2 weeks after
CSF sterilization
( usually after 2 – 10 days of treatment )
 Neonates ……..03 weeks
** N.B. In complicated cases of meningitis ,give
antibiotics for 10-14 days
Prophylaxis
 Rifampicin:
Children 5mg/kg bid x 2/7
Adults: 600 mg bid x 2/7
Pregnant contact:
Cefuroxime IM x 1 dose
Corticosteroids
 Rapid killing of bacteria releases toxic cell
products.
 This precipitates cytokine mediated infl.
response- edema & neutrophilic response.
This will lead to additional neurologic injury
with worsening of CNS Sx:
- Dexamethasone- 0.15mg/kg/dose q6hr-
2days (benefit max if given 1-2 hr before
antibiotics)
-.
Supportive care
 NPO
 IV fluid: 800-1000ml/m2/24hr(1/2-2/3rd
of maintenance)- shock treated
aggressively.
 Septic shock- dopamine
 Signs of ↑ ICP
-ET intubation& hyperventiln
(PCO2~25mmHg)
- IV lasix (1mg/kg), mannitol (0.5-1g/kg)
 Seizures- first Rx-diazepam iv,or
lorazepam
cont’d
- do serum glucose, calcium, & sodium
levels
- After initial Rx, phenytoin (loading dose
of 15-20mg/kg, maintenance 5mg/kg/d)
 Neurologic ass’t: esp.1st 72 hrs
-PR, BP, RR, Level of consciousness,
pupils, motor, Cranial nerves, Sz,
Head circumference, Urine output.
- Lab.- Sp. Gravity of urine
Meningitis - Complications
 Septic shock - DIC
 Cerebral oedema
 Seizures,
 kidney failure
 Arteritis/venous thrombosis
 Subdural effusions
 Hydrocephalus . Abscess . Brain
damage
 Deafness
Prevention
 -Vaccination & antibiotic prophylaxis
- N.meningitidis- rifampin
10mg/kg/dose q12 hr for 2 days –for
all close contacts of patients with
meningococcal meningitis.
- HIB- rifampin 20mg/kg/day,once, 4
days for all household contacts
 Washing Hands frequently
 Not share eating utensil,plates
 THANK YOU

More Related Content

Similar to meninigitis in pediatrics ppt=.pptx

CNS infections
CNS infectionsCNS infections
CNS infections
Engidaw Ambelu
 
BACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxBACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptx
HajaSovula2
 
Meningitis
MeningitisMeningitis
Meningitis
Dr-Kunj Dhyawana
 
meningitis.pdf
meningitis.pdfmeningitis.pdf
P10.cns infec
P10.cns infecP10.cns infec
P10.cns infec
gishabay
 
Meningitis
MeningitisMeningitis
Meningitis
ChukwudiAgbor
 
#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis
EpidAlert Informative Initiative
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitisamitakashyap1
 
4th sem BMLS CNS - Copy.pptx
4th sem BMLS CNS - Copy.pptx4th sem BMLS CNS - Copy.pptx
4th sem BMLS CNS - Copy.pptx
Vishwanad Negi
 
Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)
Karunesh Kumar
 
CNS Infections Siddiqui
CNS Infections SiddiquiCNS Infections Siddiqui
CNS Infections Siddiquitjsiddiqui
 
meningitis.pdf
meningitis.pdfmeningitis.pdf
meningitis.pdf
OlumayowaOdebiyi
 
Bohomolets Microbiology Lesson #3
Bohomolets Microbiology Lesson #3Bohomolets Microbiology Lesson #3
Bohomolets Microbiology Lesson #3
Dr. Rubz
 
CNS infections.pptx
CNS infections.pptxCNS infections.pptx
CNS infections.pptx
MusFa1
 
Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...
WAidid
 
Meningococcal Infection 13032024 WEDNESDAY.pptx
Meningococcal Infection 13032024 WEDNESDAY.pptxMeningococcal Infection 13032024 WEDNESDAY.pptx
Meningococcal Infection 13032024 WEDNESDAY.pptx
PulkitMittal54
 

Similar to meninigitis in pediatrics ppt=.pptx (20)

Cns
CnsCns
Cns
 
CNS infections
CNS infectionsCNS infections
CNS infections
 
BACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxBACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptx
 
Meningitis
MeningitisMeningitis
Meningitis
 
meningitis.pdf
meningitis.pdfmeningitis.pdf
meningitis.pdf
 
P10.cns infec
P10.cns infecP10.cns infec
P10.cns infec
 
Meningitis
MeningitisMeningitis
Meningitis
 
#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis#StaySafe: Alert Points for Meningococcal Meningitis
#StaySafe: Alert Points for Meningococcal Meningitis
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitis
 
4th sem BMLS CNS - Copy.pptx
4th sem BMLS CNS - Copy.pptx4th sem BMLS CNS - Copy.pptx
4th sem BMLS CNS - Copy.pptx
 
Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)
 
CNS Infections Siddiqui
CNS Infections SiddiquiCNS Infections Siddiqui
CNS Infections Siddiqui
 
meningitis.pdf
meningitis.pdfmeningitis.pdf
meningitis.pdf
 
Meningitis
MeningitisMeningitis
Meningitis
 
Bohomolets Microbiology Lesson #3
Bohomolets Microbiology Lesson #3Bohomolets Microbiology Lesson #3
Bohomolets Microbiology Lesson #3
 
COMP. MENINGITIS.ppt
COMP. MENINGITIS.pptCOMP. MENINGITIS.ppt
COMP. MENINGITIS.ppt
 
CNS infections.pptx
CNS infections.pptxCNS infections.pptx
CNS infections.pptx
 
Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...Infections and salivary gland disease in pediatric age: how to manage - Slide...
Infections and salivary gland disease in pediatric age: how to manage - Slide...
 
Meningococcal Infection 13032024 WEDNESDAY.pptx
Meningococcal Infection 13032024 WEDNESDAY.pptxMeningococcal Infection 13032024 WEDNESDAY.pptx
Meningococcal Infection 13032024 WEDNESDAY.pptx
 
Meningitis in Children
Meningitis  in ChildrenMeningitis  in Children
Meningitis in Children
 

More from MelakuSintayhu

5 - Head injuries for nurses in emergency room
5 - Head injuries for nurses in emergency room5 - Head injuries for nurses in emergency room
5 - Head injuries for nurses in emergency room
MelakuSintayhu
 
urinarycatheterization-211223113253.pptx
urinarycatheterization-211223113253.pptxurinarycatheterization-211223113253.pptx
urinarycatheterization-211223113253.pptx
MelakuSintayhu
 
Abdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptxAbdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptx
MelakuSintayhu
 
module_3_presentation_june_22_final.pptx
module_3_presentation_june_22_final.pptxmodule_3_presentation_june_22_final.pptx
module_3_presentation_june_22_final.pptx
MelakuSintayhu
 
M3-PPT-ALTOs-Nurse-Pharmacist-Training.pptx
M3-PPT-ALTOs-Nurse-Pharmacist-Training.pptxM3-PPT-ALTOs-Nurse-Pharmacist-Training.pptx
M3-PPT-ALTOs-Nurse-Pharmacist-Training.pptx
MelakuSintayhu
 
Advanced Cardiac Life support ppt2021.pptx
Advanced  Cardiac Life support ppt2021.pptxAdvanced  Cardiac Life support ppt2021.pptx
Advanced Cardiac Life support ppt2021.pptx
MelakuSintayhu
 
Abdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptxAbdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptx
MelakuSintayhu
 
1_6 practical analysis using SPSS, Part I (2).pptx
1_6 practical analysis using SPSS, Part I (2).pptx1_6 practical analysis using SPSS, Part I (2).pptx
1_6 practical analysis using SPSS, Part I (2).pptx
MelakuSintayhu
 
MSK INJURY Bsc,Nurse_121638.ppt for nurses
MSK INJURY Bsc,Nurse_121638.ppt for nursesMSK INJURY Bsc,Nurse_121638.ppt for nurses
MSK INJURY Bsc,Nurse_121638.ppt for nurses
MelakuSintayhu
 
What-is-Brain-Injury-Flora-2019-7-25.pptx
What-is-Brain-Injury-Flora-2019-7-25.pptxWhat-is-Brain-Injury-Flora-2019-7-25.pptx
What-is-Brain-Injury-Flora-2019-7-25.pptx
MelakuSintayhu
 
Power point of needle chest compressions
Power point of needle chest compressionsPower point of needle chest compressions
Power point of needle chest compressions
MelakuSintayhu
 
Bsc.NChest Injury_123210 for nurses in emergency
Bsc.NChest Injury_123210 for nurses in emergencyBsc.NChest Injury_123210 for nurses in emergency
Bsc.NChest Injury_123210 for nurses in emergency
MelakuSintayhu
 
Other Medical Emergencies for nurses in emergency
Other Medical Emergencies for nurses in emergencyOther Medical Emergencies for nurses in emergency
Other Medical Emergencies for nurses in emergency
MelakuSintayhu
 
Air way suctioning for nurses in emergency room
Air way suctioning for nurses in emergency roomAir way suctioning for nurses in emergency room
Air way suctioning for nurses in emergency room
MelakuSintayhu
 
Shock Bsc Nursing students in emergency room
Shock Bsc Nursing students in emergency roomShock Bsc Nursing students in emergency room
Shock Bsc Nursing students in emergency room
MelakuSintayhu
 
Mass casualties incident for EMT intermediate
Mass casualties incident for EMT intermediateMass casualties incident for EMT intermediate
Mass casualties incident for EMT intermediate
MelakuSintayhu
 
Head-and-spinal-cord-injury for nurse in emergency
Head-and-spinal-cord-injury for nurse in emergencyHead-and-spinal-cord-injury for nurse in emergency
Head-and-spinal-cord-injury for nurse in emergency
MelakuSintayhu
 
Airway device for nurses in emergency room
Airway device for nurses in emergency roomAirway device for nurses in emergency room
Airway device for nurses in emergency room
MelakuSintayhu
 
Power point of suctions for nurses in emergency
Power point of suctions for nurses in emergencyPower point of suctions for nurses in emergency
Power point of suctions for nurses in emergency
MelakuSintayhu
 
emt-1introductiontoemsv-2-170221033651.pdf
emt-1introductiontoemsv-2-170221033651.pdfemt-1introductiontoemsv-2-170221033651.pdf
emt-1introductiontoemsv-2-170221033651.pdf
MelakuSintayhu
 

More from MelakuSintayhu (20)

5 - Head injuries for nurses in emergency room
5 - Head injuries for nurses in emergency room5 - Head injuries for nurses in emergency room
5 - Head injuries for nurses in emergency room
 
urinarycatheterization-211223113253.pptx
urinarycatheterization-211223113253.pptxurinarycatheterization-211223113253.pptx
urinarycatheterization-211223113253.pptx
 
Abdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptxAbdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptx
 
module_3_presentation_june_22_final.pptx
module_3_presentation_june_22_final.pptxmodule_3_presentation_june_22_final.pptx
module_3_presentation_june_22_final.pptx
 
M3-PPT-ALTOs-Nurse-Pharmacist-Training.pptx
M3-PPT-ALTOs-Nurse-Pharmacist-Training.pptxM3-PPT-ALTOs-Nurse-Pharmacist-Training.pptx
M3-PPT-ALTOs-Nurse-Pharmacist-Training.pptx
 
Advanced Cardiac Life support ppt2021.pptx
Advanced  Cardiac Life support ppt2021.pptxAdvanced  Cardiac Life support ppt2021.pptx
Advanced Cardiac Life support ppt2021.pptx
 
Abdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptxAbdominopelvic quadrants and regions.pptx
Abdominopelvic quadrants and regions.pptx
 
1_6 practical analysis using SPSS, Part I (2).pptx
1_6 practical analysis using SPSS, Part I (2).pptx1_6 practical analysis using SPSS, Part I (2).pptx
1_6 practical analysis using SPSS, Part I (2).pptx
 
MSK INJURY Bsc,Nurse_121638.ppt for nurses
MSK INJURY Bsc,Nurse_121638.ppt for nursesMSK INJURY Bsc,Nurse_121638.ppt for nurses
MSK INJURY Bsc,Nurse_121638.ppt for nurses
 
What-is-Brain-Injury-Flora-2019-7-25.pptx
What-is-Brain-Injury-Flora-2019-7-25.pptxWhat-is-Brain-Injury-Flora-2019-7-25.pptx
What-is-Brain-Injury-Flora-2019-7-25.pptx
 
Power point of needle chest compressions
Power point of needle chest compressionsPower point of needle chest compressions
Power point of needle chest compressions
 
Bsc.NChest Injury_123210 for nurses in emergency
Bsc.NChest Injury_123210 for nurses in emergencyBsc.NChest Injury_123210 for nurses in emergency
Bsc.NChest Injury_123210 for nurses in emergency
 
Other Medical Emergencies for nurses in emergency
Other Medical Emergencies for nurses in emergencyOther Medical Emergencies for nurses in emergency
Other Medical Emergencies for nurses in emergency
 
Air way suctioning for nurses in emergency room
Air way suctioning for nurses in emergency roomAir way suctioning for nurses in emergency room
Air way suctioning for nurses in emergency room
 
Shock Bsc Nursing students in emergency room
Shock Bsc Nursing students in emergency roomShock Bsc Nursing students in emergency room
Shock Bsc Nursing students in emergency room
 
Mass casualties incident for EMT intermediate
Mass casualties incident for EMT intermediateMass casualties incident for EMT intermediate
Mass casualties incident for EMT intermediate
 
Head-and-spinal-cord-injury for nurse in emergency
Head-and-spinal-cord-injury for nurse in emergencyHead-and-spinal-cord-injury for nurse in emergency
Head-and-spinal-cord-injury for nurse in emergency
 
Airway device for nurses in emergency room
Airway device for nurses in emergency roomAirway device for nurses in emergency room
Airway device for nurses in emergency room
 
Power point of suctions for nurses in emergency
Power point of suctions for nurses in emergencyPower point of suctions for nurses in emergency
Power point of suctions for nurses in emergency
 
emt-1introductiontoemsv-2-170221033651.pdf
emt-1introductiontoemsv-2-170221033651.pdfemt-1introductiontoemsv-2-170221033651.pdf
emt-1introductiontoemsv-2-170221033651.pdf
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 

meninigitis in pediatrics ppt=.pptx

  • 2. outlines  Introduction  Demography and epidemology  Predisposing factors  Etiology and Epidemology  Causes of meninigitis  Bacterial meningitis  Methods of transmission  DX  S&S  Treatment
  • 3. DEMOGRAPHY AND EPIDEMIOLOGY  The highest incidence is among neonates, who are usually infected by bacteria found in the birth canal at the time of parturition. ◦ Group B streptococci (Streptococcus agalactiae) account for the majority of cases; other causes include Listeria monocytogenes, E.coli, other Gram-negative bacilli, and enterococci.  From age 1 to 23 months, the most common organisms are Streptococcus pneumoniae and Neisseria meningitidis
  • 4. Predisposing factors  Mucosal invasion of the nasopharynx  Direct extension of bacteria across a skull fracture in the area of the cribriform plate  Systemic bacteremia as with endocarditis or a urinary tract infection or pneumonia  Asplenia, corticosteroid excess, and HIV infection
  • 5. Etiology and epidemiology of meningitis con.  Lack of immunity ( IgM or igG anti capsular antibody ) to specific pathogens with young age.  recent colonization with pathogenic bacteria .  Close contact with invasive disease ( respiratory tract secration)  Crowding , poverty , black race , male .  Defect in complement (C5- C8 ) associated with recurrent meningococcal infection .
  • 6. Etiology of meningitis con…  Ventricular peritoneal shunts  CSF leake due fracture,paranasal sinus pneumococcal  Head trauma  Neurosurgical procedures  Splenic dysfunction  Immuno suppress patients with t- cell defect( AIDS,malignancy)
  • 7. Meningitis o The brain and spinal cord are covered by connective tissue layers collectively called the meninges which form the blood-brain barrier(BBB). 1-the pia mater (closest to the CNS) 2-the arachnoid mater 3-the dura mater (farthest from the CNS). The meninges contain cerebrospinal fluid (CSF). Meningitis is an inflammation of the meninges, which, if severe, may become encephalitis, an inflammation of the brain.
  • 8.
  • 9. Central Nervous System Infections  Meningitis is the most common causes of fever associated with signs and symptoms of CNS disease in children.  Specific microbes depend on : age, immune status, epidemiology of the pathogen.
  • 10. Causes of Meningitis -Bacterial Infections -Viral Infections -Fungal Infections (Cryptococcus neoformans Coccidiodes immitus) -Inflammatory diseases (SLE) Cancer -Trauma to head or spine.
  • 11. Viral cause of meninigitis  Non polio enterovirus  Mumps virus  Measles virus  Influenza virus  Herpes simplex virus
  • 12. Bacterial meningitis….. Etiological Agents:  Pneumococcal, Streptococcus pneumoniae (38%)  Meningococcal, Neisseria meningitidis (14%)  Haemophilus influenzae (4%)  Staphylococcal, Staphylococcus aureus (5%)  Tuberculous, Mycobacterium
  • 13. Meningococcal Meninigitis Etiological Agent: Neisseria meningitidis Clinical Features: sudden onset. Sudden high fever,seisures,poor feeding,headache,nausea and vomiting Reservoir: Humans only. 5-15% healthy carriers Mode of transmission: direct contact with patients oral or nasal secretions. Saliva. Incubation period: 1-10 days. Usually 2-4 days Infectious period: as long as meningococci are present in oral secretions or until 24 hrs of effective antibiotic therapy
  • 14. Cause of Bacterial Meningitis with age group • Birth - 4 wks: GBS, E.coli  4 - 12 wks: GBS, E.coli, Pneumococcus Salmonella, Listeria, H. Influenza  3 mths - 3 yrs: Pneumococcus, Meningococcus H. Influenza  3 yrs+ adult: Pneumococcus, Meningococcus
  • 15. Mode of transmission  Respiratory secretion/ droplet  Person to person contact(kissing ,saliva,contaminated food,mucus)
  • 16. Bacterial Meningitis - Pathogenesis  Infection of upper respiratory tract  Invasion of blood stream (bacteraemia) inflammation of meninges
  • 17. Investigation  LP  Blood culture  Latex particle agglutination  Countercurrent immunoelectrophoresis
  • 18.  DIAGNOSIS 1) Lumbar puncture  Between L3 & L4 or L4 & L5  Confirms DX of meningitis  CSF  Pressure …..usually elevated to 100-300 mmH2O ( Nl =50-80 mmH2O )  Gross appearance……turbid (WBC >200-400 /mm3)  WBC count (Nl =less than 5 , lymphocyte > 75% or monocytes )  Usually elevated to >1000/mm3 (100 – 10,000/mm3 or more )  Neutrophil predominance ( 75- 95% )  In 20 % of cases WBC < 250/mm3  Absent pleocytosis …….sever overwhelming sepsis with meningitis  Pleocytosis with lymphocyte predominance…….during early stages  Elevated protein …usually 100-500 mg/dl (Nl = 20 - 45 mg/dl )  Reduced glucose….usually <40 mg/dl (or <50% of serum glucose ) ( Nl =>50mg/dl or 75 %of serum glucose )  Gram stain : positive in 70-90 % of cases  Culture
  • 19.  Contraindications for LP - Increased ICP - Sever cardiopulmonary compromise - Infection of the skin overlying the site of the LP - Thrombocytopenia( < 20,000/mm3 ) : Relative c/I  Traumatic LP - Affects CSF, WBC & protein concentration - Does not affect G/S , culture & Glucose level - Repeat LP after sometime 2) Latex particle agglutination - Highly sensitive but less specific 3) Blood culture : Positive in 80 -90 % of cases 4) Countercurrent immuno electrophoresis (CIE) -Rapid & very specific
  • 20. Typical Cerebrospinal Fluid Findings in Patients with Bacterial Meningitis Cerebrospinal Fluid Parameter Typical Finding Opening pressure 200-500 mm H2O White blood cell count 1000-5000/mm3 Percentage of neutrophils ≥80% Protein 100-500 mg/dL Glucose ≤40 mg/dL CSF-to-serum glucose ratio ≤0.4 Gram stain Positive in 60%-90% Culture Positive in 70%-85% Polymerase chain reaction Promising*
  • 21. CSF  Collect 1 ml of csf in each of 3 vials Tube 1 culture and gram stain Tube 2 glucose,protein Tube 3 cell count and differential
  • 22. Meningitis: Clinical features Newborn & Infants: non-specific  Fever  Irritability  Lethargy  Poor feeding  High pitched cry, bulging AF  Convulsions,
  • 26.  TREATMENT A) Antibiotics ◦ Always use high dose ,parenteral (IV) antibiotics. ◦ Initial (empirical )choice of therapy  Vancomycin 60 mg/kg/24 hr, given every 6 hr OR  Ceftriaxone 100 mg /Kg /24 hr once per day or 50 mg/Kg /dose every 12 hrs for 7 – 10 days OR
  • 27.  Patient allergic to b-lactam antibiotics -CAF 100 mg /Kg /24hr given every 6 hr OR - Patient can be desensitized to the antibiotic ◦ If patient is immuno compromised -Ceftazidime and aminoglycoside need to be included because of risk of gram –ve bacterial meningitis e.g. P.aeruginosa ,E .coli
  • 28. Duration of antibiotic therapy a) Generally total of 10 days b) Specific ( based on etiologic agent ) in uncomplicated cases  N .meningitidis…….5 -7 days  H .influenzae type b……….7 10 days  S .Pneumoniae………..10-14 days  CSF culture –ve………7- 10 days  Gram –ve bacilli……03 weeks or 2 weeks after CSF sterilization ( usually after 2 – 10 days of treatment )  Neonates ……..03 weeks ** N.B. In complicated cases of meningitis ,give antibiotics for 10-14 days
  • 29. Prophylaxis  Rifampicin: Children 5mg/kg bid x 2/7 Adults: 600 mg bid x 2/7 Pregnant contact: Cefuroxime IM x 1 dose
  • 30. Corticosteroids  Rapid killing of bacteria releases toxic cell products.  This precipitates cytokine mediated infl. response- edema & neutrophilic response. This will lead to additional neurologic injury with worsening of CNS Sx: - Dexamethasone- 0.15mg/kg/dose q6hr- 2days (benefit max if given 1-2 hr before antibiotics) -.
  • 31. Supportive care  NPO  IV fluid: 800-1000ml/m2/24hr(1/2-2/3rd of maintenance)- shock treated aggressively.  Septic shock- dopamine  Signs of ↑ ICP -ET intubation& hyperventiln (PCO2~25mmHg) - IV lasix (1mg/kg), mannitol (0.5-1g/kg)  Seizures- first Rx-diazepam iv,or lorazepam
  • 32. cont’d - do serum glucose, calcium, & sodium levels - After initial Rx, phenytoin (loading dose of 15-20mg/kg, maintenance 5mg/kg/d)  Neurologic ass’t: esp.1st 72 hrs -PR, BP, RR, Level of consciousness, pupils, motor, Cranial nerves, Sz, Head circumference, Urine output. - Lab.- Sp. Gravity of urine
  • 33. Meningitis - Complications  Septic shock - DIC  Cerebral oedema  Seizures,  kidney failure  Arteritis/venous thrombosis  Subdural effusions  Hydrocephalus . Abscess . Brain damage  Deafness
  • 34. Prevention  -Vaccination & antibiotic prophylaxis - N.meningitidis- rifampin 10mg/kg/dose q12 hr for 2 days –for all close contacts of patients with meningococcal meningitis. - HIB- rifampin 20mg/kg/day,once, 4 days for all household contacts  Washing Hands frequently  Not share eating utensil,plates